Show simple item record

dc.contributor.authorNiyaz L.
dc.contributor.authorCan E.
dc.date.accessioned2020-06-21T09:37:38Z
dc.date.available2020-06-21T09:37:38Z
dc.date.issued2014
dc.identifier.issn1300-0659
dc.identifier.urihttps://doi.org/10.4274/tjo.67044
dc.identifier.urihttps://hdl.handle.net/20.500.12712/4787
dc.description.abstractCongenital fibrosis of the extraocular muscles (CFEOM) is a rare disorder characterized by hereditary non-progressive restrictive strabismus and blepharoptosis. Although most of the cases are bilateral and isolated, some patients may have systemic findings. CFEOM is divided into three groups as CFEOM 1, 2, and 3 according to the phenotype. Primary responsible genes are KIF21A for CFEOM type 1 and 3 and PHOX2A/ARIX gene for CFEOM type 2. Studies suggest that abnormal innervation of the extraocular muscles is the cause of muscle fibrosis. Early treatment is important because of the risk of amblyopia. Surgery is the primary treatment option for strabismus and blepharoptosis.en_US
dc.language.isoturen_US
dc.publisherTurkish Ophthalmology Societyen_US
dc.relation.isversionof10.4274/tjo.67044en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAmblyopiaen_US
dc.subjectBlepharoptosisen_US
dc.subjectStrabismusen_US
dc.titleCongenital fibrosis of the extraocular musclesen_US
dc.title.alternativeKonjenital ekstraoküler kas fibrozisien_US
dc.typereviewen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume44en_US
dc.identifier.issue4en_US
dc.identifier.startpage312en_US
dc.identifier.endpage315en_US
dc.relation.journalTurk Oftalmoloiji Dergisien_US
dc.relation.publicationcategoryDiğeren_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record